• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study.

作者信息

Weiden P J, Mann J J, Haas G, Mattson M, Frances A

出版信息

Am J Psychiatry. 1987 Sep;144(9):1148-53. doi: 10.1176/ajp.144.9.1148.

DOI:10.1176/ajp.144.9.1148
PMID:2888321
Abstract

Extrapyramidal side effects are a major limitation in the use of neuroleptics, and tardive dyskinesia is a special public health problem. Accurate clinical diagnosis of extrapyramidal syndromes is necessary for effective management. The authors compared clinicians' recognition of the major extrapyramidal syndromes in 48 psychotic inpatients with independent blind diagnoses by clinical researchers using standardized ratings. The major finding was a high rate of clinical underrecognition of all major extrapyramidal syndromes, especially tardive dyskinesia. The authors discuss the clinical predictors of nonrecognition of extrapyramidal side effects and recommend improved training in their detection.

摘要

相似文献

1
Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study.
Am J Psychiatry. 1987 Sep;144(9):1148-53. doi: 10.1176/ajp.144.9.1148.
2
Extrapyramidal syndromes caused by antipsychotics.抗精神病药物引起的锥体外系综合征。
Med Pregl. 2012 Nov-Dec;65(11-12):521-6.
3
Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.
J Geriatr Psychiatry Neurol. 1991 Oct-Dec;4(4):222-5. doi: 10.1177/089198879100400408.
4
Movement disorders associated with neuroleptic treatment.与抗精神病药物治疗相关的运动障碍。
J Clin Psychiatry. 2001;62 Suppl 21:15-8.
5
The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.迟发性运动障碍、帕金森症、静坐不能和迟发性肌张力障碍的相互关系:库拉索锥体外系综合征研究II
Schizophr Res. 1997 Aug 29;26(2-3):235-42. doi: 10.1016/s0920-9964(97)00058-3.
6
Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.氯氮平治疗精神分裂症患者的抗精神病药物所致迟发性运动障碍、帕金森症及慢性静坐不能。
J Clin Psychiatry. 1997 Jul;58(7):318-22. doi: 10.4088/jcp.v58n0706.
7
Assessment of extrapyramidal symptoms during acute neuroleptic treatment.急性抗精神病药物治疗期间锥体外系症状的评估。
J Clin Psychiatry. 1995 Mar;56(3):94-100.
8
Tardive dyskinesia and positive symptoms of schizophrenia.迟发性运动障碍与精神分裂症的阳性症状。
Acta Psychiatr Scand. 1991 May;83(5):377-9. doi: 10.1111/j.1600-0447.1991.tb05559.x.
9
Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.急性抗精神病药物所致锥体外系运动和精神综合征的识别与处理
Pharmacopsychiatry. 2000 Sep;33 Suppl 1:3-13. doi: 10.1055/s-2000-7671.
10
Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes.
Am J Psychiatry. 1992 Aug;149(8):1075-80. doi: 10.1176/ajp.149.8.1075.

引用本文的文献

1
Neurological Perspectives Should Be Integrated Into the Management of Tardive Dyskinesia-Expert Opinions and Proposed Educational Initiatives in Asia.神经学视角应融入迟发性运动障碍的管理——亚洲的专家意见及拟议的教育倡议
J Mov Disord. 2024 Jul;17(3):262-269. doi: 10.14802/jmd.24068. Epub 2024 Apr 11.
2
The Clinical and Economic Burden of Tardive Dyskinesia in Israel: Real-World Data Analysis.以色列迟发性运动障碍的临床和经济负担:真实世界数据分析。
J Clin Psychopharmacol. 2022;42(5):454-460. doi: 10.1097/JCP.0000000000001597. Epub 2022 Aug 20.
3
Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients.
编码多巴胺受体的候选基因作为精神分裂症患者抗精神病药物所致帕金森症和迟发性运动障碍风险的预测指标
Biomedicines. 2021 Jul 23;9(8):879. doi: 10.3390/biomedicines9080879.
4
The nature of bradykinesia in schizophrenia treated with antipsychotics.抗精神病药物治疗的精神分裂症患者运动迟缓的本质。
Psychiatry Res. 2019 Mar;273:537-543. doi: 10.1016/j.psychres.2019.01.058. Epub 2019 Jan 15.
5
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.抗精神病药物相关运动障碍:药物性帕金森综合征与迟发性运动障碍——病理生理学和临床管理的关键差异
Neurol Ther. 2018 Dec;7(2):233-248. doi: 10.1007/s40120-018-0105-0. Epub 2018 Jul 19.
6
The Assessment and Treatment of Antipsychotic-Induced Akathisia.抗精神病药物所致静坐不能的评估与治疗
Can J Psychiatry. 2018 Nov;63(11):719-729. doi: 10.1177/0706743718760288. Epub 2018 Apr 23.
7
Comments on Lucire and Crotty, 2011.对卢西尔和克罗蒂(2011年)的评论
Pharmgenomics Pers Med. 2016 Aug 18;9:85-7. doi: 10.2147/PGPM.S111666. eCollection 2016.
8
A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study.一项关于伊潘立酮预防精神分裂症复发的随机试验:缓解研究
CNS Drugs. 2016 Aug;30(8):735-47. doi: 10.1007/s40263-016-0345-4.
9
Evaluation of an Educational Program for Clinical Pharmacists to Conduct Standardized Assessments for Medication-Induced Movement-Related Disorders.一项针对临床药剂师进行药物性运动相关障碍标准化评估的教育项目评估
Can J Hosp Pharm. 2015 May-Jun;68(3):258-64. doi: 10.4212/cjhp.v68i3.1461.
10
Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.姑息治疗中谵妄发作的既定治疗:专家意见及对当前证据基础的综述与未来发展建议
J Pain Symptom Manage. 2014 Aug;48(2):231-248. doi: 10.1016/j.jpainsymman.2013.07.018. Epub 2014 Jan 28.